期刊文献+

系统性红斑狼疮合并急性冠状动脉综合征4例报道及文献复习 被引量:8

Systemic lupus erythematosus coexistent with acute coronary syndrome, a report of four cases with review of literature
下载PDF
导出
摘要 目的 探讨系统性红斑狼疮 (SLE)累及患者冠状动脉的流行病学、病理生理学及临床特点。方法 收集分析 4例SLE合并急性冠状动脉综合征 (ACS)患者的临床和实验室资料并复习相关文献。结果 绝经期前女性SLE患者中ACS发病率明显增高。ACS是病程长的SLE患者的重要合并症。动脉粥样硬化和血栓形成是累及冠状动脉的最主要原因 ,冠状动脉血管炎及其他与SLE活动有关的因素则较为少见。结论 SLE患者存在早发ACS ,冠状动脉病 (CAD) Objective To appraise the epidemiology, pathophysiology,clinical features and treatment of coronary artery disease in systemic lupus erythematosus. Methods 4 cases of acute coronary syndrome (ACS) in systemic lupus erythematosus patients were presented, together with the etiology and management reviewed. Results The incidence of acute coronary syndrome in premenopausal patients with SLE was significantly increased. ACS is an important complication of prolonged SLE. Atherosclerosis and thrombosis were accounted for the vast majority of coronary arterial diseases, but vasculitis of the coronary arteries and other factors related to active SLE were comparatively rare. Conclusion ACS may appear early in SLE patients and the coronary artery disease may be correlated with long course of the illness and long term use of prednisone.
出处 《上海医学》 CAS CSCD 北大核心 2003年第7期464-467,共4页 Shanghai Medical Journal
关键词 系统性红斑狼疮 合并症 急性冠状动脉综合征 流行病学 病理生理学 临床特点 Systemic lupus erythematosus Acute coronary syndrome Pathology,clinical
  • 相关文献

参考文献12

  • 1Liang MH, Mahdl LA, Costenbader K, et al. Atherosclerotic vascular disease in systemic lupus erythematosus. J Natl Med Assoc, 2002,94:813-819.
  • 2Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus: quantification olr degrees olr narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med ,1981,70 : 775-781.
  • 3Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy.Am J Med , 1975,58:243-264.
  • 4MacGregor AJ, Dhillon VB, Binder A, et al. Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosus. Ann Rheum Dis,1992,51:152-155.
  • 5Romero FI, Atsumi T, Tinahones FJ, et al. Autoantibodies against malondialdehyde-modified lipoprotein (a) in antiphospholipid syndrome. Arthritis Rheum, 1999,42:2606-2611.
  • 6Landewe RB, van den Borne BE, Breedveld FC, et al.Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet ,2000,355:1616-1617.
  • 7Rahman P, Urowitz MB, Gladman DD, et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol, 1999, 26: 2363-2368.
  • 8Ura M, Sakata R, Nakayama Y, et al. Coronary artery bypass grafting in patients with systemic lupus erythematosus. Eur J Cardiothorae Surg , 1999,15:697-701.
  • 9Rangel A, Lavalle C, Chavez E, et al. Myocardial infarction in patients with systemic lupus erythematosus with normal findings from coronary arteriography and without coronary vasculitis case reports. Angiololgy, 1999,50:245-253.
  • 10Morton KE, Gavaghan TP, Krilis SA, et al. Coronary artery bypass graft failure-an autoimmune phenomenon? Lancet, 1986,2:1353-1357.

同被引文献59

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部